Quantum computing has moved from theoretical physics to practical application, with researchers using a hybrid system to simulate large proteins. Presented at the AI for Good Global Summit in July 2026, the technology is being positioned as a powerful complement to artificial intelligence, specifically in drug discovery and molecular biology.
Simulating Biology with Hybrid Quantum Systems
A recent study, published May 5, 2026, on the platform (arXiv), demonstrated the potential of this technology. These compounds contained more than 12,000 atoms, marking the largest biologically significant molecular simulation performed using this approach to date. The researchers utilized a hybrid system that combined quantum computing with traditional supercomputers, effectively expanding the scale of studyable systems by more than forty times compared to previous methodologies.
The Intersection of AI and Quantum Computing
Discussions at the AI for Good event in Geneva, held between July 8 and July 11, 2026, underscored that quantum computing is no longer viewed as a futuristic concept but as an active phase of scientific innovation. Experts at the summit framed the technology not as a replacement for artificial intelligence, but as its essential partner.
The division of labor is clear: quantum computing provides the immense computational power required for high-fidelity simulation, while artificial intelligence offers the analytical tools necessary for decision-making. This symbiosis is expected to accelerate the development of new medicines and treatments by allowing scientists to understand complex molecular interactions with unprecedented accuracy.
Digital Preservation and Biodiversity Monitoring
The report, which involved more than 400 scientists across 40 nations, highlights a significant data gap: researchers have assessed only a fraction of known plant species and fungi. To combat this, institutions are turning to rapid digitization. Kew Gardens has digitized 7.4 million plant and fungal specimens, providing open access to data previously locked in physical archives.
AI is now being used to analyze these massive datasets. For example, AI analysis of digitized specimens confirmed that flowering times have shifted by 2.5 days per decade over the last century. Furthermore, researchers in the Congo have used mobile phone imagery and AI-assisted classification to identify potential new species within the Sabicea genus, showing how machine learning is effectively bridging the gap where traditional physical study is currently lacking.
Unresolved Challenges in Data and Scale
Despite these technological strides, substantial hurdles remain. In the realm of quantum computing, the technology has yet to reach the threshold of full superiority over classical supercomputers for general clinical applications. The current hybrid models, while successful in simulation, still require significant refinement before they can move from the laboratory to routine clinical use.
Similarly, in environmental science, the reliance on digitized records is hampered by the fact that only a small portion of global botanical and fungal collections have been digitized. In regions like Nigeria, data presence in global databases remains limited, while records from Honduras indicate that a significant share of species within protected areas are not currently covered by conservation plans. As the scientific community integrates these new computational tools, the primary question remains: how quickly can these technologies scale to match the urgency of the medical and environmental challenges they are designed to solve?
Find more reporting in our Technology section.
